Paula Cusi
Medical · Aurora, CONPI 1295386563
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,436 of the $9,320 with a category attached, or 79.8%. 29 manufacturers reported payments, led by AbbVie at 35.0% of the total. Among medical clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 416 payments — averaging $22.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Sanofi$1K
- Incyte Corporation$1K
- E.r. Squibb & Sons, L.L.C.$524
- Regeneron Healthcare Solutions, Inc.$511
- Novartis$358
- plus $2K from 23 others
What the payments were for
- Speaking & faculty fees$1,61317%
- Food & beverage$7,43680%
- Education$2703%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 88 | $3,259 |
| Sanofi | 45 | $1,181 |
| Incyte Corporation | 99 | $1,075 |
| E.r. Squibb & Sons, L.L.C. | 15 | $524 |
| Regeneron Healthcare Solutions, Inc. | 21 | $511 |
| Novartis | 25 | $358 |
| Sun Pharmaceutical Industries Inc. | 19 | $285 |
| Lilly USA, LLC | 12 | $259 |
| Pfizer | 11 | $226 |
| Johnson & Johnson | 23 | $215 |
| Dermavant Sciences, Inc. | 8 | $203 |
| Amgen | 8 | $199 |
| Galderma Laboratories, L.p. | 8 | $181 |
| UCB, Inc. | 7 | $164 |
| Sanofi-aventis U.S. LLC | 2 | $160 |
| Janssen Scientific Affairs, LLC | 1 | $118 |
| Arcutis Biotherapeutics, Inc. | 4 | $87 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $51 |
| Dermira, Inc. | 2 | $36 |
| Almirall LLC | 2 | $34 |
| LEO Pharma Inc. | 2 | $33 |
| Genentech USA, Inc. | 2 | $29 |
| Bioventus LLC | 1 | $22 |
| Merz North America, Inc. | 1 | $22 |
| Mayne Pharma Commercial LLC | 1 | $20 |
| VYNE Pharmaceuticals Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $19 |
| Medtronic | 1 | $17 |
| Organon | 3 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,320 in reported general payments places this provider in the 95th percentile of 766 medical providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 25 | $1,307 |
| Mometasone Furoate | 20 | $376 |
| Triamcinolone Acetonide | 37 | $226 |
| Ketoconazole | 13 | $171 |
Paid to pharmacies, not to this prescriber.
Other medical in Aurora
- John NovakAurora$173K
- Lindsey TunstallAurora$87K
- Michael BallardAurora$45K
- Sean LloydAurora$19K
- Jessica BarrAurora$9K
- Anastacia WallAurora$9K
- Joseph CariAurora$8K
- Anne MailhotAurora$7K
- Taylor SeeleyAurora$7K
- Christen KutzColorado Springs$610K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.